Evidence map›Paper›PMID 28264016›Full record

ArticlePloS one2017

How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study.

Guillemette Quatremère, Marguerite Guiguet, Patricia Girardi, Marie-Noëlle Liaud, Coline Mey, Cynthia Benkhoucha, Franck Barbier, Graciela Cattaneo, Anne Simon, Daniela Rojas Castro

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: a cross-sectional study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Guillemette QuatremèreAIDES, Pantin, France.
Marguerite GuiguetSorbonne Universités, UPMC Univ Paris 06, INSERM, IPLESP UMRS 1136, Paris, France.
Patricia GirardiAIDES, Pantin, France.
Marie-Noëlle LiaudAIDES, Pantin, France.
Coline MeyAIDES, Pantin, France.
Cynthia BenkhouchaAIDES, Pantin, France.
Franck BarbierAIDES, Pantin, France.
Graciela CattaneoAIDES, Pantin, France.
Anne SimonCIDAG, Department of Internal Medicine, AP-HP Hôpital Pitié-Salpétrière, Paris, France.
Daniela Rojas CastroAIDES, Pantin, France.
Inserm · FRSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSide effects of antiretroviral therapy (ART) can have a negative impact on health-related quality of life threatening long-term retention in HIV care and adherence to ART. The aim of the French community-based survey EVE was to document personal experiences with side effects, the related physician-patient communication, and solutions found to deal with them.

designCross-sectional study of women between September 2013 to September 2014.

methodsAn anonymous online questionnaire included the HIV Symptom Distress Module, which explores 20 symptoms.

resultsIn all, 301 women on ART participated in the study (median age: 49 years; median duration of ART: 14 years). They reported having experienced a median of 12 symptoms (Q1-Q3: 9-15) during the previous 12 months. Overall, 56% of them reported having found at least a partial solution to dealing with their symptoms. Women reporting financial difficulties were twice less likely to have found solutions to coping with their side effects (AOR: 0.5; 95% CI: 0.3-0.8). Feeling supported by the health-care provider (AOR: 2.1; 95% CI: 1.1-3.9) and being in contact with HIV/AIDS organisations (AOR: 1.9; 95% CI: 1.2-3.2) were positively associated with coping. Seventeen percent reported having modified their ART regimen to improve tolerance, with only 2 in 3 informing their physician afterwards. Reporting financial difficulties and living with more bothersome symptoms increased the risk of ART regimen modification without health-care provider consultation.

conclusionThe EVE study has called attention to the large number of side effects experienced by WLWHIV, only half of whom have found self-care strategies to manage their symptoms. Modification of ART regimen by the women themselves was not uncommon.

Indexed as

Adaptation, PsychologicalPerceptionAdultAgedAnti-HIV AgentsComorbidityCross-Sectional StudiesFemaleFranceHIV InfectionsHumansMaleMiddle AgedRisk FactorsSurveys and QuestionnairesAnti-HIV Agents

Identifiers

PMID28264016
PMCPMC5338806
OpenAlexW2593523572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.